WSF OpenID Connect Login
Product information
Title
Mirena®: benefits beyond contraception for up to 8 years*1
IUD – intrauterine device
- Jensen JT et al. Am J Obstet Gynecol 2022;227(6):873.e1–873.e12. Return to content
- Mirena® SmPC, Bayer. Return to content
- Costescu D et al. BMC Women's Health 2022;22(1):82 Return to content
Title
Mirena® now provides the peace of mind of continuous contraceptive protection for up to 8 years1
Mirena® provides long-lasting protection from an unintended pregnancy1
Mirena®: protect your patients with effective, long-lasting contraception1
IUD – intrauterine device
- Mirena® SmPC, Bayer. Return to content
- Jensen JT et al. Am J Obstet Gynecol 2022;227(6):873.e1–873.e12. Return to content
Title
The favorable benefit/risk profile of Mirena® has now been demonstrated through 8 years of use1,2
The safety profile of Mirena® at:
- Jensen JT et al. Am J Obstet Gynecol 2022;227(6):873.e1–873.e12. Return to content
- Mirena® SmPC, Bayer. Return to content
Title
With Mirena®, she can enjoy benefits beyond contraception with a reduction in menstrual bleeding.1,2
Discontinuation rates for both devices vary, but discontinuation due to bleeding tends to be lower with the LNG-IUS than with the Copper IUD1,3
Offer your patient Mirena® so she can experience fewer bleeding days than with a Copper IUD4
- Costescu et al. BMC Women’s Health 2022;22(1):82. Return to content
- Modesto W et al. Hum Reprod 2014;29:1393–1399 Return to content
- Backman T et al. BJOG 2000;107:335–339. Return to content
- Rana M et al. Eur Rev Med Pharmacol Sci 2012;16:230–234. Return to content
Title
Give her the confidence to focus on her family or career without the fear of an unintended pregnancy1,2
It is important to remember
that perimenopausal symptoms
do not signal an end to fertility.
For women over 40 years of age, reliable protection and convenience are of paramount importance when choosing contraception*
- Brotherston J. Br J Gen Pract 2015;65(638):e630–e632. Return to content
- Mirena® SmPC, Bayer. Return to content
Title
Mirena®: satisfaction that comes from extended contraceptive confidence1
Mirena® delivers high
rates of satisfaction:
98.7%
of women who used
Mirena® for
8 years*†1
Offer her satisfaction and peace of mind with her contraceptive choice1
- Jensen JT et al. Am J Obstet Gynecol 2022;227(6):873.e1–873.e12. Return to content
Title
Continuation rates, like satisfaction rates, were highest with the LNG-IUS1
Continuation at 12 months1
LNG-IUS
Copper IUD
Implant
Depot medroxyprogesterone acetate
Oral contraceptives
Patch
Ring
88%
84%
83%
57%
55%
49%
54%
IUD – intrauterine device; LNG-IUS – levonorgestrel-releasing intrauterine system
- Peipert JF et al. Obstet Gynecol 2011;117:1105–1113. Return to content
- Jensen JT et al. Am J Obstet Gynecol 2022;227(6):873.e1–873.e12. Return to content
- Mirena® SmPC, Bayer. Return to content
Title
Mirena®: Frequently asked questions
Below you will find answers to some commonly asked questions about the use of Mirena® for the treatment of heavy menstrual bleeding. These will support you when assessing appropriate treatment options for women in your clinical practice.
Previously, Mirena® was licensed as an IUS providing effective contraception for 6 years and for the treatment of idiopathic menorrhagia for 5 years. However, Mirena® can now remain in place for an additional 3 years if symptoms of HMB have not returned earlier and in those who wish to continue contraception with this method1
All in all, Mirena® can now remain in place to provide contraception in maximum for up to 8 years.
- Mirena® SmPC, Bayer. Return to content
Mirena® remains highly effective, providing your patients the peace of mind of continuous contraception for an additional 3 years. In an open-label extension study (N=362) there was a 0.68% cumulative pregnancy rate in Years 6–8 of Mirena® use. This was independent of patient compliance, while age and parity showed no important differences.1
- Jensen JT et al. Am J Obstet Gynecol 2022;227(6):873.e1–873.e12. Return to content
Mirena® is a long-acting reversible contraceptive method that can be particularly useful in women with heavy menstrual bleeding.1
Mirena® maintains a favorable benefit/risk profile through 8 years of use.1 For full benefit/risk information, please see the Mirena® SmPC.2
- Jensen JT et al. Am J Obstet Gynecol 2022;227(6):873.e1–873.e12. Return to content
- Mirena® SmPC, Bayer. Return to content
If your patient wishes to continue contraception, Mirena® can now remain in place for up to 8 years.
At the end of 8 years, it must be removed and replaced with a new Mirena® if the patient chooses to continue contraception with this IUS.1
- Mirena® SmPC, Bayer. Return to content
As long as symptoms of HMB remain controlled, Mirena® can stay in place for up to 8 years. In case symptoms of HMB return, Mirena® should be removed and replaced, if medically appropriate. For all women using Mirena®, the IUS must be removed after 8 years of use.1
- Mirena® SmPC, Bayer. Return to content
Recommendations
